Genmab
GMAB
HK$151.04
Share price
0.78%
Change (1 day)
-34.69%
Change (1 year)
Categories
Revenue for Genmab (GMAB)
Revenue in 2024 (TTM): HK$24.19 Billion
According to Genmab's latest financial reports the company's current revenue (TTM 
) is HK$24.09 Billion. an increase over the revenue in the year 2023 that were of HK$18.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genmab from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$24.11 B | 29.51% |
| 2023 | HK$18.61 B | 15.96% |
| 2022 | HK$16.05 B | 55.52% |
| 2021 | HK$10.32 B | -14.86% |
| 2020 | HK$12.12 B | 93.87% |
| 2019 | HK$6.25 B | 68.18% |
| 2018 | HK$3.71 B | 28.5% |
| 2017 | HK$2.89 B | 40.83% |
| 2016 | HK$2.05 B | 58.07% |
| 2015 | HK$1.30 B | 13.04% |
| 2014 | HK$1.15 B | 25.04% |
| 2013 | HK$0.91 B | 40.09% |
| 2012 | HK$0.65 B | 30.38% |
| 2011 | HK$0.50 B | -37.01% |
| 2010 | HK$0.79 B | -5.58% |
| 2009 | HK$0.84 B |